Literature DB >> 18087185

Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Hiroshi Kasugai1, Yukio Osaki, Hiroko Oka, Masatoshi Kudo, Toshihito Seki.   

Abstract

OBJECTIVE: To clarify information on and frequency of complications as well as mortality rate after radiofrequency ablation (RFA) for hepatocellular carcinoma.
METHODS: The results of a questionnaire obtained mainly from members of the Osaka Liver Cancer Study Group at 43 departments of 38 facilities were analyzed in order to clarify the current status of RFA, and information on and frequency of complications and death occurring after RFA.
RESULTS: Between January 1999 and May 2002, a total of 3,891 RFA therapies were performed percutaneously in 2,542 patients, laparoscopically in 23, and operatively in 49 (2,614 patients in total). Complications were observed in 207 of 2,614 patients (7.9%), and 9 (0.3%) died within 3 months after RFA. Among these 9 nonsurvivors, 3 had liver failure, 3 rapid progression and sarcomatous changes, 1 biliary injury, 1 gastrointestinal bleeding, and 1 acute myocardial infarction. The departments that treated larger numbers of patients per month had a smaller number of complications and deaths.
CONCLUSION: It is possible that complications of RFA can be reduced by gathering experience. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 18087185     DOI: 10.1159/000111710

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  39 in total

Review 1.  Complications after percutaneous ablation of liver tumors: a systematic review.

Authors:  Eylon Lahat; Rony Eshkenazy; Alex Zendel; Barak Bar Zakai; Mayan Maor; Yael Dreznik; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  A case of hepatocellular carcinoma treated by radiofrequency ablation confirming the adjacent major bile duct under hybrid contrast mode through a biliary drainage catheter.

Authors:  Yusuke Imai; Masashi Hirooka; Hironori Ochi; Yohei Koizumi; Yoshinori Ohno; Takao Watanabe; Yoshio Tokumoto; Teru Kumagi; Masanori Abe; Yoichi Hiasa
Journal:  Clin J Gastroenterol       Date:  2015-08-29

Review 3.  Image-guided percutaneous ablation therapies for hepatocellular carcinoma.

Authors:  Shuichiro Shiina
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 4.  Practice guidelines for ultrasound-guided percutaneous microwave ablation for hepatic malignancy.

Authors:  Ping Liang; Jie Yu; Ming-De Lu; Bao-Wei Dong; Xiao-Ling Yu; Xiao-Dong Zhou; Bing Hu; Ming-Xing Xie; Wen Cheng; Wen He; Jian-Wen Jia; Guo-Rong Lu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

5.  Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation.

Authors:  Soo Ryang Kim; Susumu Imoto; Taisuke Nakajima; Kenji Ando; Keiji Mita; Miyuki Taniguchi; Noriko Sasase; Toshiyuki Matsuoka; Masatoshi Kudo; Yoshitake Hayashi
Journal:  Hepatol Int       Date:  2009-03-21       Impact factor: 6.047

6.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

Review 7.  Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.

Authors:  Alexandre Zanchenko Fonseca; Stephanie Santin; Luiz Guilherme Lisboa Gomes; Jaques Waisberg; Marcelo Augusto Fontenelle Ribeiro
Journal:  World J Hepatol       Date:  2014-03-27

8.  Establishment of an insufficient radiofrequency ablation orthotopic nude mouse model of hepatocellular carcinoma to study the invasiveness and metastatic potential of residual cancer.

Authors:  Ning Zhang; Hua Zhu; Ye-Hao Dong; Lu Wang
Journal:  Oncol Lett       Date:  2019-07-02       Impact factor: 2.967

9.  Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.

Authors:  Tianhong Su; Junbin Liao; Zihao Dai; Lixia Xu; Shuling Chen; Yifei Wang; Zhenwei Peng; Qiuyang Zhang; Sui Peng; Ming Kuang
Journal:  Oncogene       Date:  2018-03-21       Impact factor: 9.867

10.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.